i-SEP - the alternative to allogeneic blood transfusions

i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .
i-SEP has developed and patented an innovative technology for the separation of blood components.

Technology

01

same™

i-SEP is developing a new generation of intraoperative cell salvage technology (IOCS) for use in hemorrhagic or high-risk hemorrhagic surgery, capable of recovering not only red blood cells but also the patient's platelets.

Events & news

Chronicle

11.02.22

🚨🩸“Every donation is critical and you can make a lifesaving difference.”...

🚨🩸“Every donation is critical and you can make a lifesaving difference.”... This is what appears first on the American Red Cross website, experiencing, since January 2022, its first ever national blood crisis. At…

Event

29.10.21

EACTAIC/ICCVA congress 2021

🌍🩸A world premiere: This morning the first communication of our clinical results have been presenting by Doctor Alexandre Mansour in the "Masterclass Workshop transfusion & Hemostasis" session of the EACTAIC…

News

17.12.21

same™ by i-SEP: the first intraoperative autotransfusion technology able to recover platelets as well as red blood cells

Thank you to Business France North America and French Healthcare for highlighting our innovative Intraoperative Cell Recovery technology and its benefits to patients and healthcare system: « same by i-SEP » [#FrenchHealthcare]…

All news

Expertise :
autotransfusion,
the alternative
to allogenic
transfusions

Learn more

Innovative solutions & efficiency for the patient

Technology

Events & news

Download a
press release